PMID: 9183233Jun 9, 1997Paper

Risk factors for postherpetic neuralgia

Archives of Internal Medicine
P W ChooR Platt

Abstract

The risk factors for postherpetic neuralgia (PHN), the most common complication of herpes zoster, have not been well established. To elucidate the risk factors for PHN. Automated medical, claims, and pharmacy records of a health maintenance organization were used to identify cases of PHN and obtain data on risk factors. A case-base design was used to assess the impact of various patient, disease, and treatment factors on the prevalence of PHN 1 and 2 months after developing zoster. There were 821 cases of herpes zoster that met all eligibility criteria. The prevalence of PHN more than 30 days after onset of zoster was 8.0% (95% confidence interval [CI], 6.3%-10.1%) and 4.5% (95% CI, 3.2%-6.2%) after 60 days. Compared with patients younger than 50 years, individuals aged 50 years or older had a 14.7-fold higher prevalence (95% CI, 6.8-32.0) 30 days and a 27.4-fold higher prevalence (95% CI, 8.8-85.4) 60 days after developing zoster. Prodromal sensory symptoms and certain conditions associated with compromised immunity were also associated with PHN. Systemic corticosteroids before zoster and treatment of zoster with acyclovir or corticosteroids did not significantly affect the prevalence of PHN. Increased age and prodromal sympto...Continue Reading

Citations

Jul 8, 2010·Aging Health·Joel V Chua, Wilbur H Chen
Jul 14, 2001·The Journal of Dermatology·K FujiiN Ohgou
Sep 29, 2000·BMJ : British Medical Journal·A L Cunningham, R H Dworkin
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Michael H Ossipov, Frank Porreca
Jul 13, 2011·Dermatology Research and Practice·Catriona Ooi, Vijay Zawar
Oct 31, 2012·International Journal of General Medicine·Monica TontodonatiGiustino Parruti
Nov 19, 2002·Clinics in Dermatology·John Y Koo, Theresa C Ng
Apr 24, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Schmader
Feb 27, 2004·The American Journal of Medicine·Naoki KotaniAkitomo Matsuki
Nov 4, 2000·Expert Opinion on Investigational Drugs·R SnoeckE De Clercq
Aug 26, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Patricia BruckenthalLori Reisner
Oct 10, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·R Norman HardenCarrie McClung
Jan 31, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·William T WhiteSrinivas Nalamachu
Jul 3, 2013·The Medical Clinics of North America·Kim M O'Connor, Douglas S Paauw
Oct 2, 2012·Journal of Geriatric Oncology·Tanya M WildesArti Hurria
Sep 17, 1999·Mayo Clinic Proceedings·V M MontoriB A Bauer
Oct 15, 2011·Mayo Clinic Proceedings·Michael KlompasRafael Harpaz
Apr 1, 2011·Journal of the American Medical Directors Association·Liyuan MaKenneth E Schmader
May 4, 2010·The Journal of Pain : Official Journal of the American Pain Society·Mélanie DroletJames A Mansi
Feb 26, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Won Suk ChoiHee Jin Cheong
Mar 31, 2009·The Journal of Pain : Official Journal of the American Pain Society·Lucia Gagliese
Aug 5, 2000·Mayo Clinic Proceedings·T J Liesegang
Nov 26, 2008·La Presse médicale·Pierre-Olivier LangJean-Pierre Michel
Dec 6, 2007·Journal of the American Academy of Dermatology·Jeffrey M Weinberg
Dec 6, 2007·Journal of the American Academy of Dermatology·Stephen K Tyring
Feb 3, 2007·La Revue de médecine interne·T HanslikF-P Alvarez
Aug 21, 2009·International Journal of Clinical Practice·R W Johnson, J McElhaney
Jul 24, 2008·Journal of Medical Virology·A VolpiA F Sabato
Apr 14, 2012·Muscle & Nerve·Haatem RedaLyell K Jones
Jul 30, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·Y-W YangH-W Lin
Oct 19, 2011·International Journal of Dermatology·Neerja Puri
Oct 9, 2004·Journal of Pain and Symptom Management·Charles E ArgoffMiroslav Backonja
Jul 19, 2005·Medicina clínica·Amaro GarcíaJose-Vicente Torregrosa
Oct 10, 1998·Neurologic Clinics·R S Cluff, M C Rowbotham
Aug 27, 2014·Journal of Medical Virology·Jen-Yin ChenMiao-Lin Hu
Oct 6, 2015·Advanced Biomedical Research·Shirvan RastegarKeivan Basiri
Mar 19, 2015·Human Vaccines & Immunotherapeutics·Tae Un YangWoo Joo Kim
Apr 17, 2015·BMC Public Health·Adam GaterEmmanuelle Préaud
Mar 8, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Robert JohnsonMyron Levin
Sep 29, 2001·Pain·R H DworkinD R Griffin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.